Cardamonin - CAS 19309-14-9
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
Cardamonin is a naturally occuring chalcone initially isolated from the seeds of Amomum subulatum and subsequently from other zingiberous plant species. Cardamonin exhibits its antiinflammatory activity via suppression of p65NF-κB nuclear translocation and I-κBɑ phosphorylation.
is a novel antagonist ofhTRPA1cation channel with anIC50of 454 nM.
Brife Description:
A novel antagonist of hTRPA1 cation channel (IC50= 454 nM)
(E)-1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenylprop-2-en-1-one; 2',4'-dihydroxy-6'-methoxychalcone; cardamomin; cardamonin
DMSO: ≥ 28 mg/mL
Store in a cool and dry place (or refer to the Certificate of Analysis).
Boiling Point:
484.5±45.0 ℃ at 760 Torr
Melting Point:
203-205 ℃
1.282±0.06 g/cm3
Canonical SMILES:
1.Cardamonin Alleviates Pressure Overload-induced Cardiac Remodeling and Dysfunction Through Inhibition of Oxidative Stress.
Li W;Wu X;Li M;Wang Z;Li B;Qu X;Chen S J Cardiovasc Pharmacol. 2016 Dec;68(6):441-451.
Pressure overload-induced cardiac remodeling and dysfunction progress to heart failure, which is mainly due to excessive oxidative stress. Hence, our study aimed to illustrate whether cardamonin, a kind of chalcone, could attenuate maladaptive cardiac changes and ameliorate cardiac insufficiency through its antioxidant mechanism. In vivo, our study revealed that cardamonin treatment could attenuate transverse aortic contraction-induced cardiac remodeling and dysfunction. Histological observations have suggested that cardamonin inhibited the occurrence of excessive cardiac oxidative stress and apoptosis. In vitro, we found that 3 treatments with angiotensin II (Ang II), hydrogen peroxide, and Nox4 overexpression in H9C2 cells markedly augmented intracellular oxidative stress as measured by superoxide dismutase, L-glutathione, and malonaldehyde. Conversely, cardamonin treatment notably alleviated oxidative stress induced by the 3 above-mentioned treatments. Furthermore, all 3 treatments resulted in increased apoptotic cell death, whereas cardamonin treatment reduced apoptosis in H9C2 cells. Moreover, cardamonin significantly abrogated the expression of Bax, apoptosis inducing factor, cytochrome c, and caspase-3 and caspase-9 and enhanced the expression of Bcl-2 and Bcl-xl.
2.Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
Lee JH;Jung HS;Giang PM;Jin X;Lee S;Son PT;Lee D;Hong YS;Lee K;Lee JJ J Pharmacol Exp Ther. 2006 Jan;316(1):271-8. Epub 2005 Sep 23.
Nuclear factor-kappaB (NF-kappaB) and the signaling pathways that regulate its activity have become a focal point for intense drug discovery and development efforts. NF-kappaB regulates the transcription of a large number of genes, particularly those involved in immune, inflammatory, and antiapoptotic responses. In our search for NF-kappaB inhibitors from natural resources, we identified cardamomin, 2',4'-dihydroxy-6'-methoxychalcone, as an inhibitor of NF-kappaB activation from Alpinia conchigera Griff (Zingiberaceae). In present study, we demonstrated the effect of cardamomin on NF-kappaB activation in lipopolysaccharide (LPS)-stimulated RAW264.7 cells and LPS-induced mortality. This compound significantly inhibited the induced expression of NF-kappaB reporter gene by LPS or tumor necrosis factor (TNF)-alpha in a dose-dependent manner. LPS-induced production of TNF-alpha and NO as well as expression of inducible nitric-oxide synthase and cyclooxygenase-2 was significantly suppressed by the treatment of cardamomin in RAW264.7 cells. Also, cardamomin inhibited not only LPS-induced degradation and phosphorylation of inhibitor kappaBalpha (IkappaBalpha) but also activation of inhibitor kappaB (IkappaB) kinases and nuclear translocation of NF-kappaB.
3.The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Daneshi-Maskooni M;Keshavarz SA;Mansouri S;Qorbani M;Alavian SM;Badri-Fariman M;Jazayeri-Tehrani SA;Sotoudeh G Trials. 2017 Jun 7;18(1):260. doi: 10.1186/s13063-017-1979-3.
BACKGROUND: ;The relationship between dietary components and nonalcoholic fatty liver disease (NAFLD) needs to be further investigated. The potential health benefits of cardamom have been found in some studies. Cardamom showed beneficial effect on hepatomegaly, dyslipidemia, and fasting hyperglycemia in animals. However, some adverse effects of cardamom have been reported in animals. No previous human study had been conducted on the effects of cardamom in NAFLD. This study aims to determine the effects of green cardamom (Elettaria cardamomum) supplementation on blood glucose indices, lipids, inflammatory profiles, and liver function, especially by examining irisin, paraxonase-1 (PON1) and sirtuin-1 (Sirt1) in obese patients with NAFLD.;METHODS: ;This trial is to be conducted at the polyclinic of the National Iranian Oil Company (NIOC) Central Hospital, Tehran. Eighty obese patients with NAFLD will be selected according to the eligibility criteria. The NAFLD diagnosis method is ultrasonography. Patients will be randomly divided into two groups by a random-number table (cardamom and placebo groups, two 500-mg capsules, three times/day, taken with meals for 3 months, follow-up monthly).
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 949467-71-4 TC-T 6000

TC-T 6000
(CAS: 949467-71-4)

TC-T 6000 is a potent equilibrative nucleoside transporter 4 (ENT4) inhibitor (IC50 = 74.4 nM), displaying 20-fold and 80-fold selectivity for ENT4 over ENT2 an...

LY 255262
(CAS: 124986-45-4)

This bio-active molecular is a antibacterial agent with a pyrazolidinone structure.

CAS 41931-13-9 LCS-1

(CAS: 41931-13-9)

LCS-1 is an inhibitor superoxide dismutase 1 (SOD1) inhibitor, catalyzing the conversion of superoxide ion (O2-) into H2O2 and O2 to maintain low levels of reac...

CAS 141-90-2 2-Thiouracil

(CAS: 141-90-2)

2-Thiouracil is a thiolated uracil derivative that is a known antihyperthyroid agent.

JNJ7925476 HCl
(CAS: 109085-56-5)

JNJ7925476 HCl is a novel triple monoamine uptake inhibitor. It blocks the serotonin transporter (SERT), norepinephrine transporter (NET) and dopamine transport...

CAS 98753-19-6 Cefpirome Sulfate

Cefpirome Sulfate
(CAS: 98753-19-6)

Cefpirome Sulfate is a fourth generation cephalosporin antibiotic. It was developed by German company Hoechst and France Roussel company together.

CAS 182821-27-8 Daglutril

(CAS: 182821-27-8)

Daglutril is a dual endothelin converting enzyme (ECE)/neutral endopeptidase (NEP) inhibitor used for the treatment of hypertension and heart failure andpulmona...

CAS 1800025-30-2 MGAT2-IN-1

(CAS: 1800025-30-2)

An orally active inhibitor of monoacylglycerol acyltransferase (MGAT2) (IC50= 7.8 for human, and 2.4 nM for mouse MGAT2).

Chemical Structure

CAS 19309-14-9 Cardamonin

Quick Inquiry

Verification code

Featured Items